Capital Group Private Client Services, Inc. Novo Nordisk A S Transaction History

Capital Group Private Client Services, Inc.

$9.55 Billion
Q1 2025

A detailed history of Capital Group Private Client Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 38,049 shares of NVO stock, worth $3.02 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

38,049

Previous 293,664 87.04%

Holding current value

$3.02 Million

Previous $25.3 Million 89.54%

% of portfolio

0.03%

Previous 0.25%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$69.3 - $90.95 $17.7 Million - $23.2 Million	-255,615 Reduced 87.04%	38,049 $2.64 Million
Q4 2024 Feb 13, 2025	SELL	$85.0 - $120.04 $2.21 Million - $3.12 Million	-25,972 Reduced 8.13%	293,664 $25.3 Million
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $570,464 - $696,707	-4,791 Reduced 1.48%	319,636 $38.1 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $1.18 Million - $1.42 Million	-9,650 Reduced 2.89%	324,427 $46.3 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $17.8 Million - $23.7 Million	-174,269 Reduced 34.28%	334,077 $42.9 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $5.67 Million - $6.81 Million	64,594 Added 14.56%	508,346 $52.6 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $20.1 Million - $44.1 Million	220,842 Added 99.07%	443,752 $40.4 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $168,458 - $186,462	1,080 Added 0.49%	222,910 $36.1 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $574,223 - $690,508	4,339 Added 2.0%	221,830 $35.3 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $69,016 - $91,077	673 Added 0.31%	217,491 $29.4 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $992,912 - $1.22 Million	-10,421 Reduced 4.59%	216,818 $21.6 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $3 Million - $3.54 Million	29,024 Added 14.64%	227,239 $25.3 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $89,562 - $108,263	-962 Reduced 0.48%	198,215 $22 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $351,016 - $428,629	-3,661 Reduced 1.8%	199,177 $22.3 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $17.1 Million - $21.6 Million	202,838 New	202,838 $19.5 Million

Others Institutions Holding NVO

# of Institutions

1,769

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $179B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.

Account

Capital Group Private Client Services, Inc. Novo Nordisk A S Transaction History